{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:34:50Z","timestamp":1790836490930,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jacbts.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T15:46:24Z","timestamp":1637163984000},"page":"1007-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Platelets"],"prefix":"10.1016","volume":"6","author":[{"given":"Stephanie L.","family":"Sellers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav S.","family":"Gulsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyn","family":"Zaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8305-4906","authenticated-orcid":false,"given":"Rong","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Latib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janarthanan","family":"Sathananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pibarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab","family":"Bouchareb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2021.07.008_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-29423-5_1","article-title":"Platelets: production, morphology and ultrastructure","volume":"210","author":"Thon","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib2","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1172\/JCI26891","article-title":"The biogenesis of platelets from megakaryocyte proplatelets","volume":"115","author":"Patel","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2021.07.008_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: from megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajh.25008","article-title":"The role of extracellular matrix stiffness in megakaryocyte and platelet development and function","volume":"93","author":"Leiva","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1083\/jcb.147.6.1299","article-title":"Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes","volume":"147","author":"Italiano","year":"1999","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/pr.117.014530","article-title":"Platelet signaling and disease: targeted therapy for thrombosis and other related diseases","volume":"70","author":"Yeung","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jacbts.2021.07.008_bib7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3324\/haematol.2017.182972","article-title":"Immobilized fibrinogen activates human platelets through glycoprotein VI","volume":"103","author":"Mangin","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jacbts.2021.07.008_bib8","first-page":"851945","article-title":"Innate and adaptive immunity in calcific aortic valve disease","volume":"2015","author":"Mathieu","year":"2015","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jacbts.2021.07.008_bib9","article-title":"Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification","volume":"6","author":"Rutkovskiy","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.07.008_bib10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/eurheartj\/ehy696","article-title":"Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis","volume":"40","author":"Bouchareb","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2021.07.008_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/bloodadvances.2018025817","article-title":"Inactivation of platelet-derived TGF-beta1 attenuates aortic stenosis progression in a robust murine model","volume":"3","author":"Varshney","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacbts.2021.07.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2016.01.007","article-title":"Increased Smad2\/3 phosphorylation in circulating leukocytes and platelet-leukocyte aggregates in a mouse model of aortic valve stenosis: evidence of systemic activation of platelet-derived TGF-beta1 and correlation with cardiac dysfunction","volume":"58","author":"Wang","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jacbts.2021.07.008_bib13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/ATVBAHA.113.300647","article-title":"Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells","volume":"33","author":"Cheng","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/ATVBAHA.116.308394","article-title":"Role of noncanonical Wnt signaling pathway in human aortic valve calcification","volume":"37","author":"Albanese","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000507183","article-title":"Association between serum Dickkopf-1 (DKK-1) glycoprotein and calcific deposits on cardiac valves and carotid intimal-medial thickness in hemodialysis patients","volume":"10","author":"Younis","year":"2020","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib16","article-title":"Secreted Wnt modulators in symptomatic aortic stenosis","volume":"1","author":"Askevold","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.07.008_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/ATVBAHA.109.189761","article-title":"Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis","volume":"29","author":"Ueland","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI70422","article-title":"Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life","volume":"124","author":"Hess","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2021.07.008_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.atherosclerosis.2011.12.034","article-title":"Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells","volume":"221","author":"Syvaranta","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2021.07.008_bib20","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1161\/ATVBAHA.110.217281","article-title":"Platelets: covert regulators of lymphatic development","volume":"30","author":"Bertozzi","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib21","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.cellsig.2010.05.007","article-title":"Molecular basis of lysophosphatidic acid-induced NF-kappaB activation","volume":"22","author":"Sun","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.jacbts.2021.07.008_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcvm.2019.00018","article-title":"Autotaxin and lipoprotein metabolism in calcific aortic valve disease","volume":"6","author":"Mathieu","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/cvr\/cvx089","article-title":"OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-kappaB pathway","volume":"113","author":"Nsaibia","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.07.008_bib24","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.12659\/MSM.894774","article-title":"Platelet-to-lymphocyte ratio may predict the severity of calcific aortic stenosis","volume":"21","author":"Akdag","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jacbts.2021.07.008_bib25","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jacc.2016.08.010","article-title":"Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications","volume":"68","author":"Hansson","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2018.12.056","article-title":"Detection and prediction of bioprosthetic aortic valve degeneration","volume":"73","author":"Cartlidge","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jacc.2018.12.045","article-title":"von Willebrand Factor and management of heart valve disease: JACC Review Topic of the Week","volume":"73","author":"Van Belle","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib28","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2021.07.008_bib29","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2021.07.008_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2016.12.027","volume":"151","author":"Sedaghat","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacbts.2021.07.008_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2015.02.008","article-title":"Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement","volume":"8","author":"Spangenberg","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacbts.2021.07.008_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1055\/s-0038-1639352","article-title":"CT-ADP point-of-care assay predicts 30-day paravalvular aortic regurgitation and bleeding events following transcatheter aortic valve replacement","volume":"118","author":"Kibler","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacbts.2021.07.008_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11239-019-01917-7","article-title":"Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement","volume":"48","author":"Grodecki","year":"2019","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacbts.2021.07.008_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1505643","article-title":"Von Willebrand factor multimers during transcatheter aortic-valve replacement","volume":"375","author":"Van Belle","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jamacardio.2016.0075","article-title":"von Willebrand factor abnormalities and Heyde syndrome in dysfunctional heart valve prostheses","volume":"1","author":"Blackshear","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib37","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.5551\/jat.34421","article-title":"Rapid restoration of thrombus formation and high-molecular-weight von Willebrand factor multimers in patients with severe aortic stenosis after valve replacement","volume":"23","author":"Yamashita","year":"2016","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacbts.2021.07.008_bib38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/heartjnl-2017-312514","article-title":"Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement","volume":"104","author":"Del Trigo","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2021.07.008_bib39","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007349","article-title":"Early and late leaflet thrombosis after transcatheter aortic valve replacement","volume":"12","author":"Yanagisawa","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacbts.2021.07.008_bib41","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jcin.2018.04.006","article-title":"Medium-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement","volume":"11","author":"Ruile","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacbts.2021.07.008_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmg.2018.12.003","article-title":"Computed tomography imaging in the context of transcatheter aortic valve replacement (TAVR)\/transcatheter aortic valve replacement (TAVR): an expert consensus document of the Society of Cardiovascular Computed Tomography","volume":"12","author":"Blanke","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacbts.2021.07.008_bib43","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2967\/jnumed.116.188896","article-title":"18)F-GP1, a novel PET tracer designed for high-sensitivity, low-background detection of thrombi","volume":"58","author":"Lohrke","year":"2017","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2967\/jnumed.118.212084","article-title":"Glycoprotein IIb\/IIIa receptor imaging with (18)F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study","volume":"60","author":"Kim","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13550-018-0471-8","article-title":"A\u00a0phase 1, first-in-human study of (18)F-GP1 positron emission tomography for imaging acute arterial thrombosis","volume":"9","author":"Chae","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jacbts.2021.07.008_bib46","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.07.008_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009608","article-title":"Hemodynamics and subclinical leaflet thrombosis in low-risk patients undergoing transcatheter aortic valve replacement","volume":"12","author":"Khan","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacbts.2021.07.008_bib48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ejcts\/ezz099","article-title":"Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"56","author":"D'Ascenzo","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacbts.2021.07.008_bib49","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.jacc.2020.03.048","article-title":"Hypoattenuated leaflet thickening in transcatheter and surgical aortic valves","volume":"75","author":"Kefer","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib50","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2020.03.022","article-title":"Bioprosthetic aortic valve leaflet thickening in the Evolut Low Risk Sub-Study","volume":"75","author":"Blanke","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib51","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12882-019-1637-y","article-title":"Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy","volume":"20","author":"Zou","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15420\/ecr.2019.10","article-title":"Antithrombotic therapy after transcatheter aortic valve implantation","volume":"15","author":"Lugo","year":"2020","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib54","first-page":"e8","article-title":"A\u00a0controlled trial of rivaroxaban after transcatheter aortic-valve replacement. Reply","volume":"383","author":"Dangas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib55","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib56","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009983","article-title":"Randomized trial of aspirin versus warfarin after transcatheter aortic valve replacement in low-risk patients","volume":"14","author":"Rogers","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacbts.2021.07.008_bib58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.120.046786","article-title":"Comparative efficacy and safety of oral P2Y12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials","volume":"142","author":"Navarese","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.008_bib59","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/eurheartj\/ehv526","article-title":"Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves","volume":"37","author":"Pache","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2021.07.008_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehx031","article-title":"Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke","volume":"38","author":"Vollema","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2021.07.008_bib61","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 Cardiac Computed Tomography Substudy","volume":"75","author":"Makkar","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.008_bib62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A\u00a0controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.008_bib63","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21002400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21002400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:25:54Z","timestamp":1762820754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X21002400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2452302X21002400"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.07.008","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelets","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}